Cell senescence in liver diseases: pathological mechanism and theranostic opportunity
The DOI matches its Crossref record; 186 of the 187 references it cites were found in a registry or an index.
Abstract
The liver is not oblivious to the passage of time, as ageing is a major risk factor for the development of acute and chronic liver diseases. Ageing produces alterations in all hepatic cells, affecting their phenotype and function and worsening the prognosis of liver disease. The ageing process also implies the accumulation of a cellular state characterized by a persistent proliferation arrest and a specific secretory phenotype named cellular senescence. Indeed, senescent cells have key roles in many physiological processes; however, their accumulation owing to ageing or pathological conditions contributes to the damage occurring in chronic diseases. The aim of this Review is to provide an updated description of the pathophysiological events in which hepatic senescent cells are involved and their role in liver disease progression. Finally, we discuss novel geroscience therapies that could be applied to prevent or improve liver diseases and age-mediated hepatic deregulations.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Cellular senescence, a stress-induced program causing stable cell-cycle arrest, is a hallmark of liver aging, fibrosis, and cancer.”
From Cellular senescence in human liver under normal aging and cancer (2026) · cites this paper as [3]
Citations
Cites
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699 · cited 1×
“This type of cancer is primarily associated with risk factors such as HBC and HCV infections, excessive alcohol consumption and obesity, which substantially contribute to its pathogenesis 136 .”
The serial cultivation of human diploid cell strains
Hayflick, L., & Moorhead, P. S. (1961) · Experimental Cell Research · doi:10.1016/0014-4827(61)90192-6 · Cited by 8,508
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477 · cited 5×
“Conversely, HSCs lacking functional p53 secrete specific factors that facilitate the polarization of macrophages towards a tumour-promoting phenotype through the secretion of IL-33, therefore enhancing the proliferation of premalignant cells 93–95 .”
InfluentialHallmarks of aging: An expanding universe
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2023) · Cell · doi:10.1016/j.cell.2022.11.001 · Cited by 6,549 · cited 1×
“…of TP53 (coding for p53) and different cyclin-dependent kinase (CDK) inhibitors, such as p16 and p21, which results in persistent activation of the retinoblastoma family proteins and the inhibition of transcriptional activators (E2F family) that are required for cell cycle progression 19,20 .”
The senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206 · cited 3×
“As described above, SASP encompasses a multitude of factors released by senescent cells, including cytokines, chemokines, interleukins and growth factors, such as IL-1, IL-6, C-C motif chemokine ligand 2 (CCL2) and insulin-like growth factor, among others 24 .”
Extension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975
Burden of liver diseases in the world
Asrani, S. K., Devarbhavi, H., Eaton, J., & Kamath, P. S. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.09.014 · Cited by 3,783
Cellular Senescence: Defining a Path Forward
Gorgoulis, V., Adams, P. D., Alimonti, A., Bennett, D. C., Bischof, O., Bishop, C., Campisi, J., Collado, M., Evangelou, K., Ferbeyre, G., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.005 · Cited by 3,225 · cited 6×
“Certainly, within the spectrum delineated by these two contrasting conditions, actively dividing cells can transition into alternative states, including cellular senescence 1 .”
InfluentialMechanisms of hepatic stellate cell activation
Tsuchida, T., & Friedman, S. L. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.38 · Cited by 2,909 · cited 1×
“Notably, this contradicts what is observed during liver dysfunction, in which the loss of lipid droplets is a characteristic of HSC activation 89 .”
Cellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818 · cited 4×
“…of MASLD in HFD-fed mice through the hepatic accumulation of so-called albumosomes — spherical shell-like structures in the cytoplasm formed by prefolding albumin — which can trap prefolding carnitine palmi-toyltransferase 2 thereby maintaining mitochondrial homeostasis from exhaustion 149 .”
Influential
Cited by
Items 101–142 of 142
[Research progress on cellular senescence and liver diseases].
Zhang, L. T., Hu, J. M., Wang, J. W., Li, H., & Qin, Y. J. (2026) · PubMed Central · doi:10.3760/cma.j.cn501113-20251219-00540
Zhu, T., 徐爱京, Yin, W. B., & Li, C. (2026) · Journal of Immunology Research · doi:10.1155/jimr/6574389
Senescent Human Liver Endothelial Cells Mediate CD4 + T Cell Recruitment via ICOSL
Patten, D. A., Lumley, A., Wilkinson, A. L., O'Keeffe, A., Yin, K., Shirgaonkar, N., Gao, R., DasGupta, R., Hoare, M., & Shetty, S. (2026) · Immunology · doi:10.1111/imm.70159
“There is now strong evidence that tissue senescence plays a significant role in regulating the hepatic microenvironment during CLD and the elimination of senescent cells is now being considered as a novel therapeutic approach [5].”
Predictors of HBV-associated hepatocarcinoma: a scientific review
Lobanova, M. A., Danilova, N. E., Слепцова, С. С., & Слепцов, С. С. (2026) · Yakut Medical Journal · doi:10.25789/ymj.2026.94.21
Gut Microbiota and Ageing: A Critical Crosstalk in Alcohol-Related Liver Disease
Tan, Y., Hu, Y., Cao, Z., Wang, X., Yuan, Y., & Chu, H. (2026) · Microorganisms · doi:10.3390/microorganisms14071469
Park, S., & Ahn, B. Y. (2026) · Nutrients · doi:10.3390/nu18142278
Song, Y., Li, W., Shao, Q., Huang, J., Guo, X., Wang, X., Gu, C., Ke, J., Zhu, T., Gao, X., et al. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.179143
Aging, liver, and alcohol-associated liver disease
Liu, T., Zheng, Z., Sun, H., Wang, X., & Gao, Y. (2026) · Hepatobiliary Communications · doi:10.1016/j.hbc.2026.100005
Liu, X., Yang, S., Zhang, C. H., Chen, P., & Li, J. N. (2026) · BMC Gastroenterology · doi:10.1186/s12876-026-05103-x
“Our findings are consistent with and extend previous epidemiological evidence, confirming that accelerated biological aging is significantly associated with an elevated risk of liver cancer [27].”
Ammonia Metabolism in the Aging Liver: Emerging Mechanistic Insights
Zhang, H., Liang, G., & Liu, A. (2026) · Aging Cell · doi:10.1111/acel.70639
“Senescent cells accumulate progressively in multiple organs during aging, including the liver (Sanfeliu-Redondo et al. 2024).”
Lu, S., Ma, J., Wang, X., Zhang, L., Lu, J., & Hu, J. (2026) · Clinical and Experimental Medicine · doi:10.1007/s10238-026-02258-5
Kong, R., Wang, H., Wang, N., Zhou, C., & Zhou, Y. (2026) · Research Square · doi:10.21203/rs.3.rs-9586597/v1
Sangdan, D. J. C., & Wang, J. (2026) · PubMed · doi:10.3760/cma.j.cn501113-20251206-00520
Age-related differences in liver damage and inflammation after femoral osteotomy
Rinderknecht, H., Ding, R., Wang, T., Wagner, A., Bülow, J. M., Becker, N., Köhler, K., Bundkirchen, K., Neunaber, C., & Relja, B. (2026) · GeroScience · doi:10.1007/s11357-026-02404-7
“Although, the liver has considerable regenerative capacity, aging is a significant risk factor for both acute and chronic liver dysfunction— potentially impairing its ability to respond and recover effectively after injury [23, 24].”
A methyl-β-D-galactopyranoside breath probe for early detection of hepatocellular carcinoma
Wang, F., Peng, X., Zhong, Z., He, M., Lu, Q., Li, Y., Liu, H., Li, W., Chen, G., Zhou, B., et al. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.180144
The SenKiller Mouse: Enabling Cell Type–Specific Ablation of Senescent Cells
Wu, X., Waite, E. L., Tigue, M., Gläser, B., Avrahami, D., & Kaestner, K. H. (2026) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2026.101855
Zhang, X., Chen, Z., Cheng, Z., Zhang, H., Xu, Y.-Q., Ding, C., An, T., Gong, Y., Hao, D., Xu, J., et al. (2026) · Biomedicines · doi:10.3390/biomedicines14081792
“Notably, regardless of the initial cause, these conditions may ultimately progress to liver fibrosis, cirrhosis, and hepatocellular carcinoma, driven largely by chronic inflammation, hepatocyte senescence, and extracellular matrix deposition [1,3].”
Cellular senescence is associated with age-related loss of liver zonation and hepatocyte functionPreprint
Laux, L., Aristel, A., Ali, S., Lande, K., Li, M., Evensen, K. G., Havas, A. P., Miao, Z., Zhang, J., Peters, S., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.08.743614 · Cited by 2
Hesperetin activates the Hmgcs2-Pparα-Cisd2 signaling axis and delays liver aging
Shen, Z., Teng, T.-W., Huang, Y., Lee, J.-C., Kao, C., Tzeng, T., Tung, C.-Y., Huang, W.-C., Tung, C.-W., Huang, S.-F., et al. (2026) · npj Aging · doi:10.1038/s41514-026-00479-2
The efficacy of stem cell therapy: cells or their microenvironment?
Li, Z., Yuan, W., Hao, S., Liu, F., San, C. A., Ding, Q., Sun, Y., Li, Y. X., & Zhu, Y. Z. (2026) · Stem Cell Research & Therapy · doi:10.1186/s13287-026-05251-7
The Oral‐Hepatic Axis: Epidemiological and Mechanistic Links Between Periodontal and Liver Diseases
Sahingur, S. E., Grzech‐Leśniak, K., Suslavich, S. F., & Deeb, J. G. (2026) · Journal of Periodontal Research · doi:10.1111/jre.70159
Chen, P., Wan, B., Yu, F., Zhang, Y., He, M., Wu, E., He, Y., Zhong, H., & Zhang, H. (2026) · Journal of Natural Medicines · doi:10.1007/s11418-026-02071-0
Mao, F., & Shan, K. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1899423
“Portal-zone macrophages express high levels of scavenger receptors (MARCO, CD163) and the anti-inflammatory cytokine IL-10, functioning as a tolerogenic barrier against gut-derived commensals (14).”
InfluentialWei, H.-N., Yang, C.-Y., Li, H., Wu, S.-X., Zou, Q.-Y., Zheng, Y., Miyashita, K., Yang, Y.-H., & Du, L. (2026) · Food Frontiers · doi:10.1002/fft2.70359
Wang, Y., He, Y., Yu, Q., Wang, N., Ruan, Q., Wang, H., Zhao, H., Zhang, Y., Ke, Y., Tang, C., et al. (2026) · Theranostics · doi:10.7150/thno.137790
“Cellular senescence plays “double-edged sword” roles in hepatocellular carcinoma progression through inducing persistent tumor cell proliferation arrest and senescence-associated secretory phenotype [19].”
Context-dependent duality of senescent cells in liver fibrosis
Gu, Y., Zhan, L., Di, Y., Wu, H., Zhao, T., Zhang, F., & Wu, Q. (2026) · Liver Research · doi:10.1016/j.livres.2026.09.001
“10,13 Central to this uncertainty is the poorly characterized heterogeneity of senescent cells across diverse liver lineages.”
Sun, L., Huang, K., Cheng, H., Yike, W., Yang, X., Zhang, W., Qian, J., & Zhai, Q. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1917104
“In the context of liver pathology, ageing is widely recognized as a critical contributor to the onset of acute and chronic hepatic diseases (23).”
Remote ischemic conditioning: a systemic strategy against aging
Cui, Y., Quan-ying, L., & Chen, H.-S. (2026) · npj Aging · doi:10.1038/s41514-026-00513-3
Pulsatile farnesoid X receptor activation rewires liver disease pharmacology
Zhao, G., Rao, Y., & Xu, P. (2026) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2026.08.004
Fractal and multifractal analysis of liver tissue samples from beagle dogs irradiated with 60Co
Matković, J., Trajković, J., Nenadović, A., Woloschak, G. E., Paunesku, T., & Ilić, A. Ž. (2026) · The European Physical Journal Special Topics · doi:10.1140/epjs/s11734-026-02610-6
Quan, H., Tan, H., Zhang, Y., Wang, L., Xie, S., Liang, L., Wang, J., & Wang, M. (2026) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2026.140934
Shen, Z., Thuy, T. T. D., Lu, C.-K., Nguyen, T.-S., Tung, C.-Y., Kao, C., & Tsai, T. (2026) · Gut Microbes · doi:10.1080/19490976.2026.2736902
Zhang, L., Ding, R., Zheng, D., Liu, Y., Sun, Z., Liu, M., Wu, S., Liu, G., Li, B., Zhao, Z., et al. (2026) · Biomaterials Advances · doi:10.1016/j.bioadv.2026.215196
Effects and Therapeutic Strategies of Intra-Hepatic Cellular Senescence and Regeneration
Yang, J., Li, Y., Feng, Y., Chen, Y., Li, Z., Zhang, N., Lai, M., & Zou, W. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27198675
Александровна, П. Е., Buyko, E. E., Diksas, E. B., Kaidash, O. A., Кривощеков, С. В., Sergun, V. P., Valentina, B., Ivanov, V. V., & Udut, E. V. (2026) · Bulletin of Siberian Medicine · doi:10.20538/1682-0363-2026-3-60-68
Hepatocyte senescence in metabolic dysfunction–associated steatotic liver disease (MASLD)
Pang, X., Geng, N., Lu, C., Zhao, Q., Junping, S., Xiong, Y., Li, W., & Li, J. (2026) · Hepatology Communications · doi:10.1097/hc9.0000000000001055
“[35] These cytokines stabilize the expression of aging markers like p16 via paracrine or autocrine mechanisms, trapping cells in a senescent state.”
Associations between infection and organ age gaps: results from the UK Biobank
Shi, Y., Wang, M., Zhao, S., Li, J., Ye, D., Sun, X., Mao, Y., & Guo, J. (2026) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2026.106455
Yang, Y., Chen, H., Yang, M., Li, H., Xu, W., Gong, H., Yang, Y., Mo, Y., Huang, N., Liu, J., et al. (2026) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-026-05788-4
RUNX1-BNIP3-mediated mitophagy regulates hepatocyte ferroptosis by promoting SLC25A28 degradation
Hu, Z.-Y., Wang, X.-Q., Huang, Y.-F., Lou, M., Chen, M., Wang, J.-X., Jiang, F.-W., Liu, Z.-Y., Cheng, Y., Zheng, J., et al. (2026) · Redox Biology · doi:10.1016/j.redox.2026.104465
Sulaiman, S. H., Omer, R. A., Muhammad, H. Y., Qadir, A. M., & Barzani, H. A. H. (2026) · Immunologic Research · doi:10.1007/s12026-026-09877-w
Transcriptomic Characterization of Cellular Senescence in Human Donor Livers Before Transplantation
Thorne, A. M., Stimmeder, S., Ustyantsev, K., Mulder, N., Niedernhofer, L. J., Lisman, T., Demaria, M., Berezikov, E., Kuipers, F., & de Meijer, V. E. (2026) · Aging Cell · doi:10.1111/acel.70828
Macrophage lipid metabolism: a hidden driver of aging and chronic diseases
Li, R., Tang, X., Li, Y., He, W., Zhu, Y., Li, M., Liu, B., Zou, Z., Zhang, Y., Luo, J., et al. (2026) · Science China Life Sciences · doi:10.1007/s11427-026-3490-5
Metadata
- Authors
- Sanfeliu-Redondo, D., Gibert-Ramos, A., & Gracia-Sancho, J.
- Affiliations
- Hospital Clínic de Barcelona (ES)
- Venue
- Nature Reviews Gastroenterology & Hepatology
- Published
- 2024-03-14
- Volume
- 21
- Issue
- 7
- Pages
- 477-492
- ISSN
- 1759-5045 (ISSN-L)
- 1759-5053
- OpenAlex
- W4392817758
- Cited by
- 117
- References
- 187
- Citations by year
- 2026: 65 · 2025: 42 · 2024: 10
- FWCI
- 6.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature Reviews Gastroenterology & Hepatology (publishedVersion)
- PubMed (publishedVersion)
- BORIS (University Library Bern) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- cellular senescence, chronic liver disease, hepatocellular carcinoma, senescence-associated secretory phenotype, senolytics, liver disease progression
- MeSH terms
- Aging, Humans, Liver, Liver Diseases, Cellular Senescence, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.